Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects

Solmi, Marco, Fornaro, Michele, Ostinelli, Edoardo G., Zangani, Caroline, Croatto, Giovanni, Monaco, Francesco, Krinitski, Damir, Fusar‐Poli, Paolo +1 more·2020·World Psychiatry
DOI 10.1002/wps.20765

Cited by (323)

Items 201–300 of 323

  1. Proposed protocol for the investigation of the safety and efficacy of the COVID-19 vaccine for patients with psychosis, with pilot safety findings from a Chinese psychiatrist's self-experiment.
    Chongguang Lin, Tao Fang, Jiayue Chen, Qianchen Li, Weiliang Yang, Cong Yao, Lina Wang, Yun Sun, Ziyao Cai, Jing Ping et al. · 2022 · PubMed Central
  2. Antidepressants
    Parna Haghparast, Megan E. Maroney, Aaron Salwan, Adam Sabbaugh · 2021 · Side effects of drugs annual
  3. There are no “side” effects, just “core” effects of antipsychotic pharmacotherapy
    Michele Fornaro · 2021 · Acta Psychiatrica Scandinavica
  4. Controversies regarding Lithium-associated weight gain: Case-control study of real-world drug safety data
    W. Greil, Mateo de Bardeci, Bruno Müller-Oerlinghausen, Nadja Nievergelt, Hans H. Stassen, Gregor Hasler, Andreas Erfurth, Katja Cattapan, Eckart Rüther, Johanna Seifert et al. · 2023 · Research Square
  5. Challenging use of psychotropic medication in young people
    David M. L. Branford, Anne Webster, David Gill, Teresa Randon, Kirsten Peebles · 2024 · Drug and Therapeutics Bulletin
  6. Korean Medication Algorithm Project for Bipolar Disorder 2022: Children and Adolescents
    Chan-Mo Yang, Won‐Myong Bahk, Young Sup Woo, Jong‐Hyun Jeong, Jeong Seok Seo, Il Han Choo, Won Kim, Jung Goo Lee, Myung Hun Jung, Duk‐In Jon et al. · 2022 · 신경정신의학
  7. A perspective on translating genomic discoveries into targets for brain‐machine interface and deep brain stimulation devices
    Wander L. Valentim, Daniel S. Tylee, Renato A Polimanti · 2023 · WIREs Mechanisms of Disease
  8. Zwangsstörungen im Kindes- und Jugendalter
    Susanne Walitza, Christoph Wewetzer · 2023 · Springer eBooks
  9. Chapter 60. Treatment of Child and Adolescent Disorders
    Karen Wagner, Steven R. Pliszka · 2024 · American Psychiatric Association Publishing eBooks
  10. Subjective experiences of an acceptance and mindfulness-based group intervention (Feel-Good-Group) in young people with early psychosis
    Laura von Hardenberg, Karolina Leopold, Andrea Pfennig, Céline Kuhn, Michèle Kallenbach, Navid Aliakbari, Stephanie Mehl, Andreas Bechdolf · 2024 · Frontiers in Psychiatry
  11. Antidepressant Prescription to Children/Adolescents and Its Effects on the Cardiovascular System, Comprising the Actual Questions of Periodicity of the Checkups, Cooperation among Pediatricians, Family Doctors, Cardiologists and Children-Adolescent Psychiatrists
    Reda Montvilaite · 2025 · Acta medica Lituanica
  12. Medical management of ADHD in adults: part 2
    Laurence Leaver · 2025 · Drug and Therapeutics Bulletin
  13. Medication Nonadherence in Children and Adolescents with ADHD
    Konstantin Mechler, Tobias Banaschewski, Tobias Hellenschmidt, Christoph Ulrich Correll, Frank Theisen, Michael Kaess, Michael G. Kölch, Gerhard Libal, Tobias Renner, Jörg Michael Fegert et al. · 2025 · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
  14. Duration effects of micronutrients in children with ADHD: Randomised controlled trial vs. Open-Label extension
    Adarsh Chand, Kathryn A. Darling, Julia J. Rucklidge · 2025 · European Child & Adolescent Psychiatry
  15. PK/PD modeling of the effect of Escitalopram combined with Docetaxel in the treatment of breast cancer with depression in mice
    Tianyu Wang, Junsheng Xue, Lei Cai, Chen Liu, Tian-yu Bao, Xin-yu Hou, Tianyan Zhou · 2025 · Journal of Pharmaceutical Sciences
  16. Tolerability of Antidepressants in Adolescents With Inflammatory Bowel Disease: A Small Case Series
    Luvena Kochetkova, Daniel You, Siu Tsin Au Yeung, Dina Mahmood · 2025 · Journal of Paediatrics and Child Health
  17. The off-label use of psychotropic medicines in paediatric patients in Australian primary care
    Laila Tanana, Christopher M Harrison, Prasad S. Nishtala, Timothy Frank Chen · 2025 · Psychiatry Research
  18. The Make America Healthy Again Commission and Mental Health Distrust
    William Smith, Steven S. Sharfstein, Paul S. Appelbaum · 2025 · Psychiatric Services
  19. Remote monitoring of wide-ranging real-world changes in adults following ADHD medication initiation
    Yuezhou Zhang, Alice E. Barnes, Kanyakorn Veerakanjana, Hayley Denyer, Heet Sankesara, Hannah Marriott, Phoebe Rocks, Giulia Gerboni, Andrea Mortera, Ulrich Müller-Sedgwick et al. · 2025 · Translational Psychiatry
  20. Postsystolic shortening as indicator of regional myocardial dysfunction in patients with bipolar disorder
    Cheng‐Yi Hsiao, Tzu‐Yu Hsu, Kevin Li‐Chun Hsieh, Hsin-Yi Lai, Yen‐Kuang Lin, Kuo‐Hsuan Chung, Shang‐Ying Tsai, Pao‐Huan Chen · 2026 · Journal of Psychosomatic Research
  21. Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators
    Kinga K. Tomczak, Jason P. Swindle, Firas M. Dabbous, Donald L. Gilbert, George B. Karkanias, Sarah D. Atkinson, Frederick E. Munschauer, Faizan Mazhar, Charlotte A. Pettersson, Stephen P. Wanaski et al. · 2026 · Frontiers in Psychiatry
  22. Disruptive mood dysregulation disorder and pediatric bipolar disorder: diagnostic and prescribing trends following DSM-5
    Ching-Fang Sun, Christoph Ulrich Correll, Chen-Yu Wei, Soo‐Jeong Kim · 2026 · European Child & Adolescent Psychiatry
  23. High Risk of Metabolic Side Effects Among New Paediatric Antipsychotic Users in Sweden—A Register‐Based Study
    Elin Eyfells Kimland, Anders Sundström, Sverre Wikström, Håkan Jarbin, Elin Dahlén · 2026 · Pharmacoepidemiology and Drug Safety
  24. Practical and Ethical Issues in Pediatric Psychopharmacology: Introductory Considerations
    Ji-Woo Suk, Brigette S. Vaughan, Kalika Mahato, Soonjo Hwang · 2021 · Psychiatric Annals
  25. A Review of Bipolar Disorder
    Yutong Wu, Shuo Yin · 2021 · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research
  26. Il risperidone
    Marzia Bazzoni, Carola Adragna, Sara Carucci · 2023 · Medico e Bambino
  27. Increased Interleukins: Effect of Risperidone in Individuals with Schizophrenia—a Systematic Review
    Miguel Ángel Ramos-Méndez, Carlos Alfonso Tovilla‐Zárate, Isela Esther Juárez‐Rojop, María Lilia López‐Narváez, Alma Delia Genis Mendoza, Thelma Beatriz González‐Castro, José Jaime Martínez‐Magaña, Guillermo Efrén Villar-Juárez, Marcela Bellizzia-Rodríguez, Rosa Giannina Castillo-Ávila et al. · 2023 · SN Comprehensive Clinical Medicine
  28. Mechanism of Antidepressant Action of (2R,6R)-6-Hydroxynorketamine (HNK) and Its Compounds: Insights from Proteomic Analysis
    Chaohui Zhen, Chong Wang, Yanjun Ma, Yuli Pang, Feiyue Cai, Jiali Meng, Yuefei He, Ping Xiao, Jianxi Liu, Xi Mei et al. · 2023 · Molecular Neurobiology
  29. Parenteral medication for the management of acute severe behavioural disturbance (ASBD) in the emergency department
    Elyssia M. Bourke, Kate Monico Klein, Jonathan C. Knott, Simon S. Craig, Emma J Tavender, Franz E Babl · 2024 · Cochrane Database of Systematic Reviews
  30. Population pharmacokinetics of olanzapine in pediatric patients with psychiatric disorders
    Yannan Zang, Zhou Wan, Fei Jia, Qi Joy Yang, Chengeng Liu, Qian Wang, Shanshan Liu, Fang Dong, Anning Li, José de León et al. · 2024 · Expert Opinion on Drug Metabolism & Toxicology
  31. UMA REVISÃO CRÍTICA DO IMPACTO DOS ANTIPSICODÉLICOS NA REDUÇÃO DO ESTIGMA QUE ENVOLVE A SAÚDE MENTAL E NA MELHORIA DOS RESULTADOS DO TRATAMENTO
    João Dorival Lucas da Costa Filho, Vanessa Mariano Montanha Furlaneti, Natalia Keppk Monteiro, Carlos Henrique Moulin Naumann, Daniela Borges Macedo, Matheus Budib Poleto Freitas Moro · 2024 · International Journal of Health Management Review
  32. Managing Type 1 Diabetes in an Inpatient Child Psychiatric Care Setting
    Amanda L. Olinger, Shilpa Sachdeva, Ann M. Manzardo, Sharon Cain · 2024 · Diabetes Spectrum
  33. Neuropsychopharmacotherapy in Children and Adolescents
    Susanne Walitza, Gregor Emanuel Berger, DANIEL A. GELLER, Lukasz Smigielski · 2022 · Springer eBooks
  34. Attention deficit hyperactivity disorder
    Steven M. Lazar, Robert G. Voigt · 2024 · Elsevier eBooks
  35. Risk of extrapyramidal symptoms associated with antipsychotic drugs in children and adolescents: a systematic review and meta-analysis of double-blind randomised placebo-controlled trials
    Joaquín Galvañ, Giacomo Distefano, Iván Echeverria, Clàudia Aymerich, Renzo Abregú-Crespo, Marién Martín Argila Lorente, Nadia Cruz, Laura López-Larriba, Dolores Maria Moreno, Mara Parellada et al. · 2026 · Research Square
  36. Which Are the Safest Psychotropic Medications for Children and Adolescents
    Joel Yager · 2020 · Journal watch
  37. Monitoring of metabolic adverse events of second-generation antipsychotics in a naive paediatric population followed in mental health outpatient and inpatient clinical settings: MEMAS prospective study protocol
    Marie-Line Ménard, Drigissa Ilies, Pascale Abadie, Thaïna Jean-Baptiste, Rachel Choquette, Anne-Sophie Huet, Leila Ben Amor · 2021 · BMJ Open
  38. Lithium Carbonate Treatment Alleviates Gut Inflammation Through Activating Treg Cell Responses in a Microbiota-Dependent Manner
    Shengjie Huang, Bo Tang, Li Tang, Yaojiang Liu, Shuang Liu, Yuanyuan Lei, Shiping Hu, Li Zhong, Shiming Yang, Song He · 2020 · SSRN Electronic Journal
  39. Psychotropic medication use in the Armed Forces: prescription patterns and treatment after trauma
    Debbie G. A. Janssen · 2021
  40. Neuropsychopharmacotherapy in Children and Adolescents
    Susanne Walitza, Gregor Emanuel Berger, DANIEL A. GELLER, Lukasz Smigielski · 2022 · Springer eBooks
  41. Targeting Metabolic Abnormalities in Mental Health Prevention Strategies
    Simone Schimmenti, Francesca Maria Camilla Maselli, Sarah Tosato · 2022 · Springer eBooks
  42. The Potency of Tryptophan Compound in a Combination of Bali Green Banana (Musa acuminata Colla) and Java Pineapple (Ananas comosus L. Merr) Extract and Its Opportunities as a Suppressive Self-behavior from Natural Ingredient
    Susy Purnawati, Luh Putu Wrasiati, Cokorda Bagus Jaya Lesmana · 2022 · BIO Web of Conferences
  43. Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder
    Deepa Jahagirdar, Quenby Mahood · 2022 · Canadian Journal of Health Technologies
  44. Emergence of psychiatric adverse events during antipsychotic treatment in naive children and adolescents
    Marie-Line Ménard, Philippe Auby, Coralie Cruzel, David Cohen, Olivier Bonnot, Florence Askenazy-Gittard, Suzanne Thümmler, ETAPE Study group · 2022 · Research Square
  45. Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study
    Giammarco Cascino, Rossella Ceres, Alessio Maria Monteleone, Paola Bucci, Giulia Maria Giordano, Silvana Galderisi, Palmiero Monteleone · 2022 · Journal of Clinical Medicine
  46. Delay in pharmacological treatment of autistic children after recognition of the disorder
    Antonio Clavenna, Massimo Cartabia, Ida Fortino, Olivia Leoni, Maurizio Rippa Bonati · 2022 · European Neuropsychopharmacology
  47. Assessing therapeutic response to methylphenidate among children and adolescents with Attention-Deficit Hyperactivity Disorder: Narrative Review of its effects on emotional regulation, executive functions, and quality of life
    Ivgeny Saveliev, Nitzan Shahar · 2022
  48. The Effect of Qi-Shao-Tong-Mai-An-Shen (QSTMAS) Herbal Paste in Coronary Heart Disease Patients with Depression and/or Anxiety: A Randomized Controlled Clinical Trial Protocol
    Ying Chen, Xiang Xiao, Chongxiang Xue, Shuliang Zheng, Qing He, Ruiqi Yao, Gaoyu Zhang, Li Huang · 2023 · Research Square
  49. Current treatment options in early-onset psychosis
    Anne Katrine Pagsberg, Marianne Melau · 2023 · Elsevier eBooks
  50. COMPARISON BETWEEN THE MANAGEMENT AND OUTCOME OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC DRUGS OVERDOSE: A STUDY FROM THE NATIONAL ENVIRONMENTAL AND CLINICAL TOXICOLOGY RESEARCH CENTRE, CAIRO UNIVERSITY HOSPITALS
    Ahmed Fathy, eman zohairy, Nevine El Kady, Iman Abdelrasheed, Amani Abdel Fattah · 2023 · The Egyptian Journal of Forensic Sciences and Applied Toxicology
  51. Association between serum uric acid and age and the prevalence of hyperuricemia in patients with psychiatric disorders: A cross-section study
    Guodong Yang, Shuang Zhou, Yue Feng, Jiaran Lang, Huipeng Ren · 2023 · Research Square
  52. Analyzing the network of parent‐rated ADHD symptoms before and 2 weeks after the onset of pharmaceutical treatment
    Payam S. Shabestari, Sareh Zendehrouh, Atefeh Ahmadi, Sajad Jafari, Nooshin Parvaresh, Mahin Eslami Shahrbabaki · 2023 · Journal of Child and Adolescent Psychiatric Nursing
  53. Psychotropic Medication
    Paige A. Weir, Celeste M. Tevis, Johnny L. Matson · 2023 · Autism and child psychopathology series
  54. Arzneimittel- und Medizinproduktschäden – Begutachtung
    Roland Seifert, Hardy Landolt, Jürgen Fritze · 2023 · Springer Reference Medizin
  55. Phytotherapy of abnormality of fear memory: A narrative review of mechanisms
    Shaojie Yang, Guoqi Zhu · 2023 · Fitoterapia
  56. Oral antipsychotic medication use in children and adolescents in Japan between 2013 and 2021
    Sachiko Tanaka‐Mizuno, Motomu Suga, Rie Matsushita, Hiroshi Ohashi, Masato Takeuchi, Koji Kawakami · 2023 · Research Square
  57. Attention de ne pas diaboliser la prescription des psychotropes chez l’enfant et l’adolescent
    Jean Chambry · 2023 · Enfances & Psy
  58. Psychostimulanzien und andere Arzneistoffe, die zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) angewendet werden
    Susanne Walitza, Lukasz Smigielski, Manfred Gerlach · 2023 · Springer eBooks
  59. Angststörungen und Phobien
    Susanne Walitza, Tobias Johann Renner, Siebke Melfsen · 2023 · Springer eBooks
  60. Additional file 4 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
    Spyridon Siafis, Çıray, Oğulcan, Hui Wu, Johannes Schneider‐Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn et al. · 2022 · Figshare
  61. Additional file 7 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
    Spyridon Siafis, Çıray, Oğulcan, Hui Wu, Johannes Schneider‐Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn et al. · 2022 · Figshare
  62. Le traitement des troubles anxieux: version courte
    Erich Seifritz, Josef A. Hättenschwiler, PD Ulrich Michael, Guido Bondolfi, Martin Preisig, Stefan Rennhard, Martin Hatzinger, Susanne Walitza, Annette Beatrix Brühl, Edith Holsboer‐Trachsler · 2024 · Forum Médical Suisse ‒ Swiss Medical Forum
  63. Tratamiento psicofarmacológico de la esquizofrenia en la población infantojuvenil: estado del arte
    María Florencia Iveli · 2024 · Vertex Revista Argentina de Psiquiatría
  64. Die Behandlung der Angsterkrankungen: Kurzversion
    Erich Seifritz, Josef A. Hättenschwiler, PD Ulrich Michael, Guido Bondolfi, Martin Preisig, Stefan Rennhard, Martin Hatzinger, Susanne Walitza, Annette Beatrix Brühl, Edith Holsboer‐Trachsler · 2024 · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
  65. The effect of Qi‐Shao‐Tong‐Mai‐An‐Shen herbal paste on coronary heart disease patients with depression and/or anxiety: Study protocol for a randomized controlled trial
    Ying Chen, Xiang Xiao, Lin Li, Chaozeng Si, Hong Jiang, Mingjing Shao, Xiao‐Yan Lu, Shuliang Zheng, Tian‐Gu Dai, Qing He et al. · 2024 · Advanced Chinese Medicine
  66. Modafinil Use in an Adolescent With Major Depressive Disorder.
    Ecem Özer Çakır, O. Karakuş, Ibrahim Adak · 2024 · Journal of Clinical Psychopharmacology
  67. Die Aufmerksamkeitsdefizit-Hyperaktivitäts-Störung – eine Spektrumdiagnose
    Oskar G. Jenni · 2024 · Springer eBooks
  68. Somatic Symptoms in a Population-Based Sample from Childhood to Adolescence: Stability and Concurrent and Longitudinal Predictors
    Sara K. Pardej, Daniel A. Waschbusch, Susan L. Calhoun, Susan Dickerson Mayes · 2024 · Child Psychiatry & Human Development
  69. Registered Nurses’ Promotion of Children’s Participation During Medication Follow-Up in Child and Adolescent Psychiatric Outpatient Care
    Sonia Rönning, Rose‐Marie Johansson‐Pajala, Susanne Olofsdotter, Kent W. Nilsson, Maria Härder · 2025 · Issues in Mental Health Nursing
  70. Prescribing in Children and Adolescents
    2025 · Wiley eBooks
  71. Dialectical Behavioral Therapy Skills Training for Adolescents with Attention Deficit Hyperactivity Disorder: A Pilot Study
    Irina Landin, Sean G. Perrin, Pia Tallberg, Jonas Borell, Peik Gustafsson · 2025 · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
  72. Arzneimittel- und Medizinproduktschäden
    Roland Seifert, Hardy Landolt, Jürgen Fritze · 2025 · Springer Reference Medizin
  73. Drug-Induced Movement Disorders in Children
    Donald L. Gilbert · 2025 · Elsevier eBooks
  74. Clinical Profiles and Medication Predictors in Early Childhood Psychiatric Referrals: A 10-Year Retrospective Study
    Leyla Bozatlı, Hasan Cem Aykutlu, Cansu Uğurtay Dayan, Tuğçe Ataş, Esra Nisa Arslan, Yeşim Özge Gündüz Gül, İşık Görker · 2025 · Medicina
  75. Psychosocial and Behavioral Disorders in Children and Adolescents with Diabetes Mellitus: Pearls and Practice Tips
    Safinaz Adel Elhabashy, Hanan Hassan Aly, Reham Ibrahim Abdelmageed · 2025 · Springer eBooks
  76. Korean Medication Algorithm Project for Depressive Disorder 2025 (III): Child and Adolescent
    Chan-Mo Yang, Se-Hoon Shim, Won‐Myong Bahk, Jeong Seok Seo, Nak-Young Kim, Won-Seok Choi, Young Sup Woo, Sung‐Yong Park, Won Kim, Jung Goo Lee et al. · 2025 · 신경정신의학
  77. Prevalence and characteristics of off‐label use of antidepressants in paediatric patients in China
    Xinyan Zhang, Jie Li, Ning Zhang, Tiebang Liu, Tianmei Si, Xiaoyan Nie, Luwen Shi · 2025 · General Psychiatry
  78. Additional file 1 of Lithium use in childhood and adolescence, peripartum, and old age: an umbrella review
    Delfina Janiri, Gaia Sampogna, Umberto Albert, Filippo Caraci, Martinotti, Giovanni, Gianluca Serafini, Tortorella, Alfonso, Alessandro Zuddas, Fiorillo, Andrea, Sani, Gabriele · 2024 · Figshare
  79. Additional file 1 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
    Spyridon Siafis, Çıray, Oğulcan, Wu, Hui, Johannes Schneider‐Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn et al. · 2022 · Figshare
  80. Additional file 5 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
    Spyridon Siafis, Çıray, Oğulcan, Wu, Hui, Johannes Schneider‐Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn et al. · 2022 · Figshare
  81. Additional file 1 of Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents
    Menard, Marie-Line, Philippe Auby, Coralie Cruzel, David Cohen, Olivier Bonnot, Florence Askenazy-Gittard, Susanne Thümmler · 2022 · Figshare
  82. Additional file 6 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
    Spyridon Siafis, Çıray, Oğulcan, Wu, Hui, Johannes Schneider‐Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn et al. · 2022 · Figshare
  83. Additional file 1 of Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment
    Choi, Hangnyoung, Kim, Jae Han, Hee Sang Yang, Jong Yeob Kim, Samuele Cortese, Lee Smith, Koyanagi, Ai, Elena Dragioti, Radua, Joaquim, Paolo Fusar‐Poli et al. · 2024 · Figshare
  84. Additional file 2 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
    Spyridon Siafis, Çıray, Oğulcan, Wu, Hui, Johannes Schneider‐Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn et al. · 2022 · Figshare
  85. Additional file 3 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
    Spyridon Siafis, Çıray, Oğulcan, Wu, Hui, Johannes Schneider‐Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn et al. · 2022 · Figshare
  86. Additional file 1 of Controversies regarding lithium-associated weight gain: case–control study of real-world drug safety data
    W. Greil, Mateo de Bardeci, Bruno Müller-Oerlinghausen, Nadja Nievergelt, Hans H. Stassen, Gregor Hasler, Andreas Erfurth, Katja Cattapan, Eckart Rüther, Johanna Seifert et al. · 2023 · Figshare
  87. Psychosocial and Behavioral Disorders in Children and Adolescents with Diabetes Mellitus: Pearls and Practice Tips
    Safinaz Adel Elhabashy, Hanan Hassan Aly, Reham Ibrahim Abdelmageed · 2025 · Springer eBooks
  88. The effects of exercise and rTMS on depression symptoms in adolescents depression
    Yaxin Tang, Yaxiang Jia, Da Li, Qiner Li, Jingyi Wang, Quan Fu · 2025 · Frontiers in Psychology
  89. Non-Pharmacological Approaches to Addressing Overweight and Obesity in Children and Adolescents with Mental Illness: A Scoping Review of Quantitative and Qualitative Evidence
    Annika Nordkamp, Grete Teilmann, Martin Jorsal, Justina Petersen, Julie Midtgaard · 2025 · Behavioral Sciences
  90. A time-resolved fluorescent signal tag-mediated immunochromatographic assay for the rapid and sensitive detection of fluoxetine
    Wenjia Yang, Lu Zeng, Xinyu Zhang, Xiangrui Li, Qiujin Zhu · 2026 · Journal of Food Composition and Analysis
  91. Off‐label use of medications in psychiatry: the need and the caveats
    Eduard Vieta · 2026 · World Psychiatry
  92. Metabolic indexes of obesity in major depressive disorders in different age groups
    Jieyu Zhou, Yukang Tan, Shasha Huang, Yajie Zhang, Jiaquan Liang · 2026 · Medicine
  93. Psychopharmakotherapie
    Hans-Christoph Steinhausen · 2026 · Elsevier eBooks
  94. Pharmacological treatment of obsessive-compulsive disorder in children and adolescents: An overview
    Aarya Krishnan Rajalakshmi, Aditya Kumar Singh Pawar, Raman Baweja · 2026 · World Journal of Clinical Pediatrics
  95. Locomotor and endocrine alterations link to metabolic dysfunction induced by pathopharmacological interaction between neurodevelopmental disorders and antipsychotics: evidence from clinical and animal study
    Menglu Zeng, Xinyu Yang, Zhenju Cao, Huiyu Chen, Yanfang Lu, Chen Xu, Danlin Weng, Anying Shen, Fei Xue, Wei Lin et al. · 2026 · Frontiers in Psychiatry
  96. Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles
    Matthew H. Bennett, Ethan A. Poweleit, Samuel E. Vaughn, Brandon Retke, Paul C. Toren, Jeffrey Robert Strawn, Laura B. Ramsey · 2026 · Clinical and Translational Science
  97. Tricky “Ticcy” Case: Tics/Tourette Syndrome with Co-occurring OCD
    Lilian Ebner, Ariadne Kaylor, Angela Essa, Erica Greenberg, Jeremiah M. Scharf · 2026 · Springer eBooks
  98. Innovative Approaches to Depression Therapy: The Antidepressant Efficacy and Mechanisms of General Anesthetics
    Xiangying Wei, Shan Xu, Zhaoqiong Zhu · 2026 · Current Neuropharmacology
  99. Modern tactics of diagnosis and treatment of tic disorders
    O.Yu. Sukhonosova, Tetyana Litovchenko, S.M. Korenev, О.L. Tondiy · 2026 · INTERNATIONAL NEUROLOGICAL JOURNAL
  100. Pharmacotherapy
    Franklin Sunzeri · 2026 · Springer eBooks